The concordance study of MSI status between MSI testing (FALCO) and modified Bethesda panel (GI-SCREEN-CRC-MSI additional study 02)

The concordance study of MSI status between MSI testing (FALCO) and modified Bethesda panel (GI-SCREEN-CRC-MSI additional study 02) - The concordance study of MSI status between MSI testing (FALCO) and modified Bethesda panel (GI-SCREEN-CRC-MSI additional study 02)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036361

Enrollment

435

Registered

2019-04-01

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Participate in GI-SCREEN MSI study 2) Patient who can provide written informed consent for secondary use of samples 3) Obtaining MSI status by MSI testing (FALCO) 4) Enough DNA samples

Exclusion criteria

Exclusion criteria: 1)Patients who are unfit for the study as determined by the attending physician

Design outcomes

Primary

Measure	Time frame
Sensitivity and Specificity	—

Countries

Japan

Contacts

Public ContactHiroya Taniguchi

National Cancer Center Hospital East Department of Gastroenterology and Gastrointestinal Oncology

hirtanig@east.ncc.go.jp04-7133-1111

Outcome results